Reduce bladder cancer recurrence in patients treated for upper urinary tract urothelial carcinoma: The REBACARE-trial

BACKGROUND: Following radical nephro-ureterectomy for urothelial carcinoma of the upper urinary tract (UUT), the reported bladder recurrence rate of urothelial carcinoma is 22–47%. A single intravesical instillation of chemotherapy within 10 days following nephro-ureterectomy has the potential to de...

詳細記述

保存先:
書誌詳細
出版年:Contemp Clin Trials Commun
主要な著者: van Doeveren, T., van Leeuwen, P.J., Aben, K.K.H., van der Aa, M., Barendrecht, M., Boevé, E.R., Cornel, E.B., van der Heijden, A.G., Hendricksen, K., Hirdes, W., Kooistra, A., Kroon, B., Leliveld, A.M., Meijer, R.P., van Melick, H., Merks, B., de Reijke, T.M., de Vries, P., Wymenga, L.F.A., Wijsman, B., Boormans, J.L.
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2018
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5898538/
https://ncbi.nlm.nih.gov/pubmed/29696234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.conctc.2018.01.007
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料